1008848 - Acorda Therapeutics Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - ACOR (1008848)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
75 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S36+0-0-0-27

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-10-09
ACORLawrence DavidChief, Bus. Ops, PAOS - Sale$25.40-2508,686-3%-$6,350
2017-08-29
ACORScopia Capital Management LP10%P - Purchase$19.23+766,2018,474,728+10%+$14,730,449
D
2017-08-01
ACORRauscher Steven MDirM - OptEx$18.21+10,0000-100%+$182,100
D
2017-08-01
ACORRauscher Steven MDirS - Sale+OE$21.57-10,0000-100%-$215,703
D
2017-08-01
ACORGreene Barry EDirM - OptEx$18.21+10,0000-100%+$182,100
D
2017-08-01
ACORGreene Barry EDirS - Sale+OE$21.57-10,0000-100%-$215,697
D
2017-07-31
ACORRandall LorinDirM - OptEx$18.21+10,0000-100%+$182,100
D
2017-07-31
ACORRandall LorinDirS - Sale+OE$21.66-10,0000-100%-$216,615
2017-06-16
ACORCohen RonPres, CEOP - Purchase$16.95+20,000554,588+4%+$338,998
2017-05-15
ACORHindman Andrew A.Chief Business Dev. OfficerS - Sale$15.75-7,70446,123-14%-$121,319
D
2017-03-01
ACORWasman JanePres, Intl, GCA - Grant$0.00+5,000106,674+5%+$00+11-23
D
2017-03-01
ACORSabella Lauren MChief Commercial OfficerA - Grant$0.00+4,40016,349+37%+$00+11-23
D
2017-03-01
ACORLawrence DavidChief, Bus. Ops, PAOA - Grant$0.00+4,4008,936+97%+$00+11-23
D
2017-03-01
ACORHindman Andrew A.Chief Business Dev. OfficerA - Grant$0.00+4,60053,827+9%+$00+11-23
D
2017-03-01
ACORCohen RonPres, CEOA - Grant$0.00+11,960534,588+2%+$00+11-23
D
2017-03-01
ACORBlight AndrewChief Scientific OfficerA - Grant$0.00+2,03678,594+3%+$00+11-23
D
2017-03-01
ACORBlank BurkhardChief Medical OfficerA - Grant$0.00+4,20044,200+11%+$00+11-23
D
2017-03-01
ACORBatycky Richard P.Chief Tech. Officer, Site HeadA - Grant$0.00+4,40050,316+10%+$00+11-23
D
2017-02-09
ACORWasman JanePres, Intl, GCM - OptEx$22.13+54,536101,674+116%+$1,206,882-2+4+12
D
2017-02-09
ACORWasman JanePres, Intl, GCS - Sale+OE$22.30-54,536101,674-35%-$1,216,218-2+4+12
D
2017-02-09
ACORLawrence DavidChief, Bus. Ops, PAOM - OptEx$22.13+63,1834,536-108%+$1,398,240-2+4+12
D
2017-02-09
ACORLawrence DavidChief, Bus. Ops, PAOS - Sale+OE$22.32-63,1834,536-93%-$1,410,542-2+4+12
D
2017-02-09
ACORGreene Barry EDirM - OptEx$22.13+7230-100%+$16,000-2+4+12
D
2017-02-09
ACORGreene Barry EDirS - Sale+OE$22.65-7230-100%-$16,376-2+4+12
D
2017-02-09
ACORBlight AndrewChief Scientific OfficerM - OptEx$22.13+67,58676,558+753%+$1,495,678-2+4+12
D
2017-02-09
ACORBlight AndrewChief Scientific OfficerS - Sale+OE$22.41-67,58676,558-47%-$1,514,379-2+4+12
D
2017-01-03
ACORGreene Barry EDirM - OptEx$15.91+3,0170-100%+$48,000+20+4
D
2017-01-03
ACORGreene Barry EDirS - Sale+OE$19.26-3,0170-100%-$58,113+20+4
D
2016-12-14
ACORCohen RonPres, CEOM - OptEx$15.49+40,172522,628+8%+$622,264-6-15-1
D
2016-12-14
ACORCohen RonPres, CEOS - Sale+OE$20.75-40,172522,628-7%-$833,655-6-15-1
2016-12-01
ACORWasman JanePres, Intl, GCS - Sale$20.73-3,347101,674-3%-$69,400+2+1-3
2016-12-01
ACORSabella Lauren MChief Commercial OfficerS - Sale$20.74-2,42911,949-17%-$50,381+2+1-3
2016-12-01
ACORLawrence DavidChief, Bus. Ops, PAOS - Sale$20.74-4,4164,536-49%-$91,594+2+1-3
2016-12-01
ACORHindman Andrew A.Chief Business Dev. OfficerS - Sale$20.72-44349,227-1%-$9,180+2+1-3
2016-12-01
ACORCohen RonPres, CEOS - Sale$20.74-7,160522,628-1%-$148,482+2+1-3
2016-12-01
ACORBlank BurkhardChief Medical OfficerS - Sale$20.74-10,00040,000-20%-$207,442+2+1-3
2016-12-01
ACORBlight AndrewChief Scientific OfficerS - Sale$20.76-4,85576,558-6%-$100,774+2+1-3
2016-10-21
ACORBatycky Richard P.Chief Tech. Officer, Site HeadS - Sale$20.30-2,06345,916-4%-$41,877-2-12+3-18
2016-10-07
ACORLawrence DavidChief, Bus. Ops, PAOS - Sale$20.82-2508,952-3%-$5,205-3-2-11-16
2016-10-03
ACORWasman JanePres, Intl, GCS - Sale$20.78-3,750105,021-3%-$77,9270-5-15-18
D
2016-09-23
ACORWasman JanePres, Intl, GCM - OptEx$8.50+500108,7710%+$4,250-4-9-15+14
D
2016-09-23
ACORWasman JanePres, Intl, GCS - Sale+OE$27.32-500108,7710%-$13,660-4-9-15+14
D
2016-08-09
ACORBlight AndrewChief Scientific OfficerM - OptEx$22.13+9,75481,413+14%+$215,856+1+20+4
D
2016-07-01
ACORBlank BurkhardChief Medical OfficerA - Grant$0.00+50,00050,000New+$0+1-1-2-23
D
2016-06-22
ACORLawrence DavidChief of Business OperationsM - OptEx$8.50+5009,202+6%+$4,250-4-3-1-30
D
2016-06-22
ACORLawrence DavidChief of Business OperationsS - Sale+OE$25.09-5009,202-5%-$12,545-4-3-1-30
D
2016-06-10
ACORWasman JanePres, Intl, GCM - OptEx$22.13+8,647108,771+9%+$191,358-2-4-7-18
D
2016-06-08
ACORRauscher Steven MDirM - OptEx$18.65+1,0860-100%+$20,254-2-6-7-26
D
2016-06-08
ACORRauscher Steven MDirS - Sale+OE$27.83-1,0860-100%-$30,224-2-6-7-26
2016-05-13
ACORHindman Andrew A.Chief Business Dev. OfficerS - Sale$26.11-4,86049,670-9%-$126,885+20-2-22
D
2016-04-19
ACORRandall LorinDirM - OptEx$18.65+1,4880-100%+$27,751+2-1-12-31
D
2016-04-19
ACORRandall LorinDirS - Sale+OE$28.68-1,4880-100%-$42,676+2-1-12-31
D
2016-02-04
ACORCohen RonPres, CEOM - OptEx$9.36+29,238529,788+6%+$273,740-3-9+1-31
D
2016-01-04
ACORSmith Ian FDirM - OptEx$18.30+13,2310-100%+$242,093-1-2-11-39
D
2016-01-04
ACORSmith Ian FDirS - Sale+OE$41.85-13,2310-100%-$553,706-1-2-11-39
D
2015-12-23
ACORWasman JanePres, Intl, GCM - OptEx$5.85+10,751100,124+12%+$62,893-1-2-12-43
D
2015-12-23
ACORWasman JanePres, Intl, GCS - Sale+OE$43.10-10,751100,124-10%-$463,395-1-2-12-43
D
2015-12-22
ACORWasman JanePres, Intl, GCM - OptEx$5.85+5,342100,124+6%+$31,25100-9-41
D
2015-12-22
ACORWasman JanePres, Intl, GCS - Sale+OE$42.43-13,797100,124-12%-$585,43200-9-41
D
2015-12-22
ACORSabella Lauren MChief Commercial OfficerM - OptEx$22.06+7,11314,378+98%+$156,91300-7-39
D
2015-12-22
ACORSabella Lauren MChief Commercial OfficerS - Sale+OE$42.04-7,11314,378-33%-$299,06300-7-39
2015-12-21
ACORWasman JanePres, Intl, GCS - Sale$42.00-817108,579-1%-$34,314+2+3-9-40
D
2015-12-18
ACORLawrence DavidChief of Business OperationsM - OptEx$5.92+39,0269,202-131%+$230,931+2+3-9-40
D
2015-12-18
ACORLawrence DavidChief of Business OperationsS - Sale+OE$40.63-39,0269,202-81%-$1,585,488+2+3-9-40
D
2015-12-17
ACORWasman JanePres, Intl, GCM - OptEx$6.00+3,277109,396+3%+$19,662+2+2-11-41
D
2015-12-17
ACORWasman JanePres, Intl, GCS - Sale+OE$40.00-3,277109,396-3%-$131,080+2+2-11-41
D
2015-12-17
ACORSabella Lauren MChief Commercial OfficerM - OptEx$22.06+14,22914,378>999%+$313,892+2+2-11-41
D
2015-12-17
ACORSabella Lauren MChief Commercial OfficerS - Sale+OE$40.00-14,22914,378-50%-$569,160+2+2-11-41
2015-12-01
ACORWasman JanePres, Intl, GCS - Sale$38.08-5,523109,396-5%-$210,294+3+2+15-21
2015-12-01
ACORSabella Lauren MChief Commercial OfficerS - Sale$38.06-7,10614,378-33%-$270,481+3+2+15-21
2015-12-01
ACORRogers Michael WCFOS - Sale$38.06-96440,713-2%-$36,689+3+2+15-21
2015-12-01
ACORLawrence DavidChief of Business OperationsS - Sale$38.08-7,1679,202-44%-$272,954+3+2+15-21
2015-12-01
ACORHindman Andrew A.Chief Business Dev. OfficerS - Sale$38.26-44254,530-1%-$16,911+3+2+15-21
2015-12-01
ACORCohen RonPres, CEOS - Sale$38.08-11,850500,550-2%-$451,225+3+2+15-21
2015-12-01
ACORCarrazana Enrique J.Chief Medical OfficerS - Sale$38.08-7,21832,148-18%-$274,869+3+2+15-21

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top